Dr. Reddy's works on quality; Patheon to manufacture Flexion product;

> Executives of Dr. Reddy's Laboratories says the company is investing in its quality systems to meet FDA standards. Report

> Flexion Therapeutics ($FLXN) hired Patheon to manufacture its steroid candidate. Report

> AAIPharma Services Corp./Cambridge Major Laboratories will manufacture the API for Atossa Genetics' ($ATOS) drug candidate. Report

> A new report says the global ampoules and blister packaging market hit $10.3 billion last year and will grow 6.24% CAGR for the next 5 years to hit $14.8 billion. Report

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.